Skip to main content
. 2023 Mar 27;15(4):1075. doi: 10.3390/pharmaceutics15041075

Figure 1.

Figure 1

Permeation profiles of IBU over time for the commercially available formulations, Ibuleve and Nurofen, in human epidermis, expressed as (A) cumulative amounts (μg/cm2) and (B) percentages (%) of the dose applied (n = 5; mean ± SD).